Induction of remission
|
COAP protocol (Use for 6–10 weeks, then use LMP) |
cyclophosphamide (Cytoxan©) 200–300 mg/m2, PO, every 3 weeks |
vincristine (Oncovin©) 0.5 mg/m2BSA, IV, once a week |
cytosine arabinoside (Cytosar-U©) 100 mg/m2BSA/day, IV drip or SQ, for 2 days |
(Note: cytosine arabinoside may cause pain or discomfort upon subcutaneous injection in cats) |
prednisone 50 mg/m2BSA, PO, sid for a week; then 20 mg/m2BSA PO, every other day |
Intensification
|
doxorubicin (Adriamycin©) 25 mg/m2, IV, every 3 weeks or |
mitoxantrone (Novantrone©) 4–6 mg/m2, IV, every 3 weeks |
Maintenance (Use until relapse occurs; then go to ‘rescue’) LMP protocol |
chlorambucil (Leukeran©) 20 mg/m2BSA, PO, every other week |
methotrexate (Methotrexate©) 2.5 mg/m2BSA, PO, 2–3 times per week |
prednisone 20 mg/m2, PO, every other day |
COAP protocol |
use as above every other week for six treatments, then every third week for additional six treatments, and try to maintain the patient on one treatment every 4th week. |
Maintenance therapy is continued until the tumour relapses |
Rescue
|
MiC protocol (21 day cycle) |
mitoxantrone (Novantrone©) 4–6 mg/m2, IV drip over 4–6 h on day 1 |
cyclophosphamide (Cytoxan©) 200–300 mg/m2, PO, day 15 or 16 |
AC protocol (21 day cycle) |
doxorubicin (Adriamycin©) 25 mg/m2, IV, on day 1 |
cyclophosphamide (Cytoxan©) 200–300 mg/m2, PO, day 15 or 16 |
MiCA protocol (21 day cycle) |
mitoxantrone (Novantrone©) 4–5 mg/m2, IV drip over 4–6 h on day 1 |
cyclophosphamide (Cytoxan©) 200–300 mg/m2, PO, day 15 or 16 |
cytosine arabinoside (Cytosar-u©) 200 mg/m2, IV drip over 4–6 h |
(Mixed in the same bag with mitoxantrone) on day 1 |
CHOP protocol (21 day cycle) |
cyclophosphamide (Cytoxan©) 200–300 mg/m2, IV, on day 10 |
doxorubicin (Adriamycin©) 20–25 mg/m2, IV, on day 1 |
vincristine (Oncovin©) 0.5 mg/m2, IV, on days 8 and 15 |
prednisone 20–25 mg/m2, PO, every other day |